Digital AI is redefining decision-making in biopharma R&D AI has kickstarted a new wave of innovation in biopharma R&D.
Digital Digital tools must be used in pharma manufacturing to keep p... The pace of change in drug discovery and clinical development has been unmatched in recent years, with technologies such as AI accelerating these processes.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.